Author: Nisha Cooch

Dr. Nisha Cooch

Nisha Kaul Cooch is Founder and Principal of BioInnovation Consulting LLC, a life sciences communications firm based in Washington DC. While earning her PhD in Neuroscience, she studied the nature of decision making and information processing. The focus of her current work is entrepreneurship in the biotechnology industry.

Types of Dementia

Dementia is a term that is often used broadly to refer to the loss of cognitive abilities, but there are a number of different forms of dementia. Here, we will outline common forms of dementia, as well as the symptoms and brain changes associated with each dementia type. Alzheimer’s disease

Eye Conditions May Provide Diagnostic Clues Regarding Alzheimer’s Risk

Unlike most diseases, there is not one test that can definitively diagnose Alzheimer’s disease. Although brain scans can help rule out other possible causes when abnormal symptoms develop, such as strokes or brain tumors, a single test, scan, or exam cannot detect whether or not a patient is living with

Patients on Kidney Dialysis Have a Higher Risk of Dementia

There is no denying the importance of dialysis for patients living with potentially fatal kidney diseases. Being a life-saving treatment, this intervention allows patients to better manage their illnesses. As stated by the National Kidney Foundation, nearly 500,000 Americans currently rely on this treatment to survive.  However, researchers are now

The Connecting Through Art in Dementia Care Program Is Providing Patients with a Sense of Purpose

The London Arts Council and McCormick Care Group have partnered up to provide individuals with dementia an opportunity. Working alongside artists, dementia patients are becoming co-creators of visual art, drama, dance, and music. This program, known as Connecting through Art in Dementia Care (CAIDC), draws on the memories of dementia

Bill Gates & Other Philanthropists Contribute $30 Million To Accelerate Alzheimer’s Diagnostic Test Research

Bill Gates has certainly made himself known within the Alzheimer’s community. In the past, he has expressed his concerns following his father’s diagnosis. By the time his father was 92 years old, he was, as Gates described, “deeply affected.” This made Gates worry about his own neurological health. After experiencing